Healthcare Services

An Important Factor Driving the Diphtheria Market Is the Rising Prevalence Of Bacterial Infections Fuels Growth In The Diphtheria Market

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Diphtheria Market Expected To Change Between 2026 And 2030?

The diphtheria market has seen substantial growth in recent years. It is anticipated to expand from $9.39 billion in 2025 to $9.96 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.1%. The growth observed in prior periods is attributable to historical disease outbreaks, limited vaccination coverage, poor sanitation conditions, lack of early diagnosis, and uneven healthcare access.

The diphtheria market is anticipated to experience robust expansion in the coming years. It is projected to reach $13.05 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.0%. This projected increase over the forecast timeframe stems from factors such as worldwide immunization efforts, enhanced access to diagnostics, increased public health funding, digitalization of disease surveillance, and comprehensive outbreak preparedness initiatives. Key trends anticipated during this period encompass sustained demand for vaccination and immunization schemes, a heightened emphasis on timely diagnosis and monitoring, an expanding application of antibiotic and antitoxin treatments, the broadening of public health awareness drives, and the reinforcement of systems for tracking infectious diseases.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp

Which Major Factors Are Driving The Expansion Of The Diphtheria Market?

An increasing number of bacterial infections is projected to advance the diphtheria market in the coming years. A bacterial infection is defined as an ailment or state caused by the multiplication of bacteria or the toxins they produce within the body. Diphtheria is a severe infection resulting from bacterial strains that weaken the immune system and foster the spread of Corynebacterium diphtheria. To illustrate this trend, the Centers for Disease Control and Prevention, a US-based government agency, indicated in March 2024 that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, signifying an increase of 1,295 cases. Thus, the growing incidence of bacterial infections is set to fuel the diphtheria market.

How Is The Diphtheria Market Structured Across Different Segments?

The diphtheria market covered in this report is segmented –

1) By Type: Diphtheria, Skin Diphtheria, Other Types

2) By Diagnosis: Physical Examination, Throat Culture, Other Diagnosis

3) By Treatment: Antibiotics, Antitoxin, Other Treatments

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Diphtheria: Respiratory Diphtheria, Non-respiratory Diphtheria

2) By Skin Diphtheria: Cutaneous Diphtheria

3) By Other Types: Diphtheritic Myocarditis, Diphtheritic Neuritis

How Are Trends Shaping The Direction Of The Diphtheria Market?

Leading firms within the diphtheria market are increasingly adopting sophisticated formulation approaches, particularly thermostabilisation technology, to boost distribution effectiveness, temperature endurance, and liberation from cold-chain requirements. These thermostabilisation technologies represent cutting-edge formulation techniques designed to safeguard vaccine antigens against deterioration from heat or varying temperatures, thereby facilitating attributes like stability at ambient temperatures, less product spoilage, and enhanced delivery to remote locations. An illustrative example is Stablepharma Ltd, a UK-based biotechnology company, which initiated Phase 1 clinical trials in April 2025 for SPVX02. This innovative tetanus–diphtheria vaccine is designed to be fridge-free, preserving its effectiveness even after exposure to temperature variations between −20°C and +40°C, and offering an extended shelf life of up to 18 months at room temperature, thanks to its heat-resistant antigen preservation and capacity for deployment without a cold chain. SPVX02 thus significantly enhances vaccine stability, bolsters supply-chain dependability, and expands accessibility in areas with limited infrastructure.

Which Major Players Dominate The Diphtheria Market?

Major companies operating in the diphtheria market are Sanofi Pasteur, GlaxoSmithKline plc, Serum Institute of India Pvt Ltd, Biological E Limited, Bharat Biotech International Limited, Panacea Biotec Ltd, Mitsubishi Tanabe Pharma Corporation, KM Biologics (Meiji Holdings), AJ Vaccines, Bionet‑Asia, Wuhan Institute of Biological Products, Walvax Biotechnology Co Ltd, Chengdu Institute of Biological Products Co Ltd, Minhai Biotechnology, Bio Farma Persero, Indian Immunologicals Ltd, LG Chem Ltd, Astellas Pharma Inc, Takeda Pharmaceutical Company Limited, MassBiologics, Shanghai Institute of Biological Products Co Ltd, Changchun Institute of Biological Products Co Ltd, Hualan Biological Engineering Inc, Valneva SE, Pasteur Institute of India, Beijing Tiantan Biological Products Co Ltd, Chongqing Zhifei Biological Products Co Ltd, Shenzhen Kangtai Biological Products Co Ltd.

Read the full diphtheria market report here:

https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report

Which Region Currently Holds The Largest Share Of The Diphtheria Market?

Asia-Pacific was the largest region in the diphtheria market in 2025. The regions covered in the diphtheria market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Diphtheria Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13016&type=smp

Browse Through More Reports Similar to the Global Diphtheria Market 2026, By The Business Research Company

Porcine Epidemic Diarrhea Vaccines Global Market Report

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Lenalidomide Global Market Report

https://www.thebusinessresearchcompany.com/report/lenalidomide-global-market-report

Naphthalene Sulfonate Global Market Report

https://www.thebusinessresearchcompany.com/report/naphthalene-sulfonate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795